Libido Enhancement is often paired with hormone evaluation, stress and sleep work, GLP1 or metabolic support (when weight or body image affect desire), and relationshipcentered coaching resources
Hamann A, Matthaei S
[31] Tempesta E, Troncon R, Janiri L, Colusso L, Riscica P, Saraceni G, Gesmundo E, Calvani M, Benedetti N, Pola P.Int J Clin Pharmacol Res
Data from cardiovascular outcomes trials suggest that GLP-1 agonists provide cardioprotective effects independent of weight loss, including reduced myocardial infarction rates and improved heart failure outcomes
These data suggest that glucagon agonism provides additional liver fat reducing efficacy beyond what is expected from weight loss alone
Tirzepatide tends to produce slightly greater body weight reduction than semaglutide in head-to-head analyses, making it ideal for people seeking maximum results